期刊文献+

多西他赛所致不良反应报告分析 被引量:21

Analysis on adverse drug reactions induced by docetaxel
原文传递
导出
摘要 目的:分析某院多西他赛所致不良反应(adverse drug reaction,ADR)的特点及临床表现,总结ADR发生时的处理措施,为临床安全有效的使用多西他赛提供依据。方法:对某院2007—2013年上报的多西他赛所致ADR进行回顾性分析。结果:某院发生多西他赛所致ADR的患者主要为中老年人(年龄≥45岁)。原患疾病以肺癌(32.26%)、乳腺癌(27.42%)及妇科肿瘤(24.19%)为主,因此女性患者较多。临床表现以过敏反应、消化系统反应及骨髓抑制居多。结论:使用多西他赛前,医护人员可以根据患者病情采取一定的预防措施;使用后,一旦发生ADR,需根据ADR的类型,及时有效的处理,只有这样才能更好地保证患者的用药安全。 OBJECTIVE To promote the rational use of docetaxel,the characteristics of adverse drug reactions(ADR)induced by docetaxel and clinical symptoms were analyzed to provide references for docetaxel administration.METHODS A retrospective analysis was performed according to ADR report forms collected from2007 to 2013.RESULTS The probability of ADR occurrence was the highest in patients≥45 years.In all ADR cases,the diseases of patients were mainly focused on lung cancer(32.26%),mammary cancer(27.42%)and gynecological oncology(24.19%).Thus,most of the patients were female.The most common clinical symptoms for ADR were anaphylactic reaction,gastrointestinal toxicity and bone marrow depression.CONCLUSION Preventive measures should be adopted according to the patients' conditions before using docetaxel.Once ADR occurs,effective treatments must be performed immediately based on ADR type to ensure the drug safety for patients.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第6期536-539,共4页 Chinese Journal of Hospital Pharmacy
基金 山东省药学会临床药学奥赛康中青年科研资助项目(编号:Sdpa-ask-2012-01)
关键词 多西他赛 药物不良反应 分析 docetaxel ADR analysis
  • 相关文献

参考文献3

二级参考文献49

  • 1白宏,左小明.奥沙利铂致15例过敏反应分析[J].江苏药学与临床研究,2005,13(3):56-56. 被引量:10
  • 2何伟珍,吴丽兰,应小飞,徐璐敏.浙江丽水市2004年501例药品不良反应报告分析[J].中国药房,2005,16(10):774-775. 被引量:162
  • 3彭杰文,梁汉霖,张俊凯,萧剑军,张朝珍.钙镁合剂联合谷胱甘肽和卡马西平预防奥沙利铂神经毒性疗效观察[J].中国药房,2006,17(8):602-604. 被引量:9
  • 4赵滨红.87例中药制剂不良反应报告分析[J].中国药房,2007,18(18):1417-1418. 被引量:14
  • 5Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures[J]. Semin Oncol, 2002,29 ( Suppl 15 ) : 21.
  • 6Saif MW. Hypersensitivity reactions associated with oxali- platin[J]. Expert Opin Drug Saf, 2006,5 ( 5 ) : 687.
  • 7Tonini G, Santini D, Vincenzi B, et al. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer pa- tients[J]. J Biol Pegul Homeost Agents, 2002,16 ( 2 ) : 105.
  • 8de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J]. J Clin Oncol, 2000,18(16) : 2 938.
  • 9Jensen SA, Baeksgaard L, Petersen LN, et al. Cardiotox- icity induced by 5-fluorouracil or capecitabine[J]. Ugeskr Laeger, 2010,172 ( 1 ) : 48.
  • 10Alter P, Herzum M, Soufi M, et al. Cardiotoxicity of 5- fluorouracil[J]. Cardiovase Hematol Agents Med Chem, 2006,4(1 ): 1.

共引文献73

同被引文献157

引证文献21

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部